摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(+)-2-N,N-dimethylamino-3-phenyl-1-propylchloride hydrochloride | 74492-03-8

中文名称
——
中文别名
——
英文名称
(S)-(+)-2-N,N-dimethylamino-3-phenyl-1-propylchloride hydrochloride
英文别名
(+)-(S)-1-chloro-2-dimethylamino-3-phenylpropane hydrochloride;(S)-2-(dimethylamino)-3-phenylpropyl chloride hydrochloride;S-dimethyl(1-benzyl-2-chloroethyl)amine hydrochloride;S-1-Chloro-2-(dimethylamino)-3-phenylpropane, hydrochloride
(S)-(+)-2-N,N-dimethylamino-3-phenyl-1-propylchloride hydrochloride化学式
CAS
74492-03-8
化学式
C11H16ClN*ClH
mdl
——
分子量
234.169
InChiKey
KWUHCYZKWOBDIU-MERQFXBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.82
  • 重原子数:
    14.0
  • 可旋转键数:
    4.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    3.24
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

点击查看最新优质反应信息

文献信息

  • Benzazepine and benzothiazepine derivatives
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04902684A1
    公开(公告)日:1990-02-20
    Vasodilating activity is exhibited by compounds having the formula ##STR1## wherein X can be --S--or --CH.sub.2 --; and R.sub.2 is ##STR2## depending upon the definition of X.
    具有通式##STR1##的化合物表现出血管舒张活性,其中X可以是--S--或--CH₂--;而R₂是##STR2##,这取决于X的定义。
  • (η6-Arene)ruthenium(II) complexes containing enantiomerically pure (β-aminoalkyl)phosphines or a (β-aminoalkyl) phosphinite: synthesis, stereochemical and kinetic studies
    作者:Carmela G. Arena、Stefania Calamia、Felice Faraone、Claudia Graiff、Antonio Tiripicchio
    DOI:10.1039/b003514i
    日期:——
    The chiral P–N* ligands [(S)-2-(dimethylamino)-3-phenylpropyl]diphenylphosphine, (S)-phephos, 1, [(S)-2-(dimethylamino)-2-phenylethyl]diphenylphosphine, (S)-phglyphos, 2, [(S)-2-(dimethylamino)-3-methylbutyl]diphenylphosphine, (S)-valphos, 3, and [(+)-(2S,3R)-4-(dimethylamino)-3-methyl]-2-diphenylphosphinoxy-1,2-diphenylbutane, (+)-(2S,3R)-chiraldphos, 4, reacted with [Ru(η6-arene)Cl2]2 (arene = p-cymene, benzene or hexamethylbenzene), in dichloromethane or tetrahydrofuran solution, affording the corresponding [Ru(η6-arene)(P–N*)Cl2] complexes, 5, in which the P–N* acts as a monodentate P-bonded ligand. In methanol the same reactions easily afforded the corresponding chelate complexes [Ru(η6-arene)(P–N*)Cl]Cl. Using ligands 1–3, when the arene is p-cymene, 90∶10 diastereomeric mixtures of the cationic complexes have been obtained while only one diastereomer was formed in the corresponding reactions when the arene is benzene or hexamethylbenzene. The determination of the absolute configuration of the major products as RRu,SC diastereoisomers was made from the crystal structure and CD spectra comparison of the complex (RRu,SC)-[Ru(η6-p-MeC6H4Pri)(S-phglyphos)Cl]BF4. Complexes [Ru(η6-arene)(P–N*)Cl]Cl were also obtained by adding small amounts of methanol to solutions of [Ru(η6-arene)(P–N*)Cl2] in chloroform. A kinetic study, in CDCl3 solution containing variable amounts of methanol, on the chelation process in the neutral species [Ru(η6-arene)(P–N*)Cl2] showed first-order behaviour of the kobs values with the nucleophile (methanol) concentration. The pseudo-first-order rate constants are ascribed to replacement of Cl− by a molecule of methanol. A reaction mechanism is proposed.
    手性 PâN* 配体[(S)-2-(二甲基基)-3-苯基丙基]二苯基膦,(S)-phephos,1,[(S)-2-(二甲基基)-2-苯基乙基]二苯基膦、(S)-phglyphos, 2, [(S)-2-(二甲基基)-3-甲基丁基]二苯基膦, (S)-valphos, 3, 和 [(+)-(2S,3R)-4-(二甲基基)-3-甲基]-2-二苯基膦氧基-1、在二氯甲烷四氢呋喃溶液中,[(+)-(2S,3R)-chiraldphos, 4]与[Ru(δ-6-蒈烯)Cl2]2(蒈烯=对-甲苯、苯或六甲基苯)反应、得到相应的[Ru(δ-6-烯烃)(PâN*)Cl2]配合物 5,其中 PâN* 作为单价 P 键配体。在甲醇中,同样的反应很容易得到相应的螯合物 [Ru(δ-6-蒈烯)(PâN*)Cl]Cl。在使用配体 1â3 时,当烯烃为对-甲苯时,可以得到 90â¶10 个非对映异构体的阳离子络合物混合物,而当烯烃为苯或六甲基苯时,在相应的反应中只能形成一个非对映异构体。根据(RRu,SC)-[Ru(δ-6-p-MeC6H4Pri)(S-phglyphos)Cl]BF4 复合物的晶体结构和 CD 光谱比较,确定了主要产物为 RRu,SC 非对映异构体的绝对构型。在氯仿中的[Ru(δ-6-蒈烯)(PâN*)Cl2]溶液中加入少量甲醇,也可得到络合物[Ru(δ-6-蒈烯)(PâN*)Cl]Cl。在含有不同量甲醇的 CDCl3 溶液中,对中性物质 [Ru(δ-6-烯)(PâN*)Cl2]的螯合过程进行的动力学研究表明,kobs 值随亲核剂(甲醇)浓度的变化呈一阶行为。伪一阶速率常数归因于 Clâ 被一分子甲醇置换。提出了一种反应机理。
  • Stereoselective reactions. XIX. Asymmetric dihydroxylation of olefins by employing osmium tetroxide-chiral amine complexes.
    作者:Kiyoshi TOMIOKA、Yuichi SHINMI、Kunihiko SHIINA、Makoto NAKAJIMA、Kenji KOGA
    DOI:10.1248/cpb.38.2133
    日期:——
    Enantioselective dihydroxylation of E-stilbene afforded (1S, 2S)-1, 2-diphenyl-1, 2-ethanediol in 70% ee by employing a stoichiometric amount of osmium tetroxide-chiral amine 5, prepared from N-methylephedrine and 2-bromopyridine.
    使用一定量的四氧化锇手性胺 5(由 N-甲基麻黄碱和 2-溴吡啶制备)对 E-二苯乙烯进行对映体选择性二羟基化,可得到(1S, 2S)-1, 2-二苯基-1, 2-乙二醇,eee 为 70%。
  • Unsymmetrical terdentate phosphorus-nitrogen-nitrogen (PNN) ligands: effect of the M/L ratio and the pendant group on stereoselectivity
    作者:Xiaohui Cheng、King Kuok (Mimi) Hii
    DOI:10.1016/s0957-4166(03)00361-6
    日期:2003.7
    Twelve novel, unsymmetrical terdentate pyrrolidine-based phosphorus-nitrogen ligands were prepared. These ligands promoted very high catalytic activity in the palladium-catalysed allylic substitution reactions of 1,3-diphenylpropenyl acetate with malonate esters (100% conversion at 0degreesC in <2 h). Enantioselectivities up to 94% were attained. An unusual effect of metal-to-ligand ratio was observed. Various structural features affecting the enantioselectivity and stereoinduction were examined and discussed. (C) 2003 Elsevier Ltd. All rights reserved.
  • Chiral (.beta.-aminoalkyl)phosphines. Highly efficient phosphine ligands for catalytic asymmetric Grignard cross-coupling
    作者:Tamio Hayashi、Mitsuo Konishi、Motoo Fukushima、Koichi Kanehira、Takeshi Hioki、Makoto Kumada
    DOI:10.1021/jo00161a013
    日期:1983.7
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫